NHS England became the world’s first health service to roll out circulating tumour DNA (ctDNA) testing for suspected lung cancer in 2025 Synnovis* have supported this initiative from its pilot phase and now provide ctDNA testing for over a third of eligible NHS patients in England including those from South London, Kent, Sussex, Surrey, West [...]
Validation work undertaken by Synnovis Biomedical Scientist, Molly Rutherford, has the potential to significantly improve the blood transfusion experience for patients receiving daratumumab, a treatment widely used for multiple myeloma. Multiple myeloma is the second most common blood cancer worldwide. Although it remains incurable, major advances in treatment have significantly improved patient outcomes, particularly following [...]
To mark World Hepatitis Day on 28 July, Synnovis and NHS Trust colleagues in South East London are expanding routine blood testing in a one-day initiative to include screening for blood borne viruses, helping more people access early diagnosis and care. There are nearly two million new cases of hepatitis B and C each year. [...]
The rapid digital PCR test for Spinal Muscular Atrophy (SMA) developed by Synnovis* is a first for England SYNLAB is delighted to recognise the Synnovis Monogenics team, based at Guy’s Hospital in London, for their contribution to making the addition of Spinal Muscular Atrophy (SMA) testing to England’s newborn screening programme possible. Our team developed [...]
SYNLAB UK & Ireland is delighted to announce the appointment of Tom Evans as Chief Executive Officer of Synnovis, its NHS partnership in South East London. The appointment reflects the strategic importance of Synnovis to both SYNLAB UK & Ireland and SYNLAB Group, and signals the next stage in the delivery of its agreed operating […]
We are delighted to announce that the Synnovis hub has officially achieved BREEAM Excellent Certification! Building Research Establishment Environmental Assessment Method (BREEAM) is one the longest running assessors for sustainability. By achieving a BREEAM Excellent certification, Synnovis is showing it’s committed to our Environmental, Social, and Governance (ESG) goals. An excellent rating indicates that the building has […]
Synnovis released this infographic to celebrate the second anniversary of its Blackfriars hub and to capture the scale and scope of what has been achieved. The first live pathology samples were processed at the hub on 2 April 2024. Since then, the volume of tests processed has doubled year on year, with 22.5million tests processed in [...]
Synnovis has achieved Cyber Essentials Plus (CE+) Accreditation following an independent Audit. CE+ is the highest level of certification for cyber security currently recommended by the UK government. It involves an intense technical audit, including device checks and internal and external scans, to verify that core controls implemented by an organisation are working effectively. This […]
Synnovis, a pathology partnership between Guy’s and St Thomas’ NHS Foundation Trust, King’s College Hospitals NHS Trust and SYNLAB, has completed the forensic investigation of the data stolen from our systems following the ransomware cyberattack we experienced last year. This calculated attack on critical UK healthcare infrastructure impacted almost all Synnovis IT systems and resulted […]
We are pleased to offer a new digital PCR test for the rapid diagnosis of Spinal Muscular Atrophy (SMA), a severe, progressive neuromuscular disorder caused by genetic mutations or deletions of the SMN1 gene. SMA patients present as “floppy infants”, with early onset of muscle weakness and failure to achieve motor milestones. In the most [...]
